THE BEHAVIORAL TOXICITY OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS

被引:48
作者
HINDMARCH, I
机构
[1] University of Surrey, Milford Hospital Godalming, Surrey
关键词
BEHAVIORAL TOXICITY; CHOICE REACTION TIME; CRITICAL FLICKER FUSION THRESHOLD; MAJOR DEPRESSION; SEROTONIN REUPTAKE INHIBITORS; TRICYCLIC ANTIDEPRESSANTS;
D O I
10.1097/00004850-199501004-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The serotonin reuptake inhibitors (SSRIs) are generally better tolerated than the traditional tricyclic antidepressants (TCAs) in the treatment of major depression. In particular the SSRIs are relatively free from cognitive and psychomotor effects Likely to cause behavioural toxicity. Behavioural toxicity is studied using a battery of psychometric assessments. This paper discusses the effects of the TCAs and SSRIs on two such assessments, choice reaction time (CRT) and critical flicker fusion threshold (CFFT). CRT measures psychomotor speed, and CFFT assesses the information processing capacity of the CNS. The behavioural toxicity associated with the traditional TCAs can lead to an increased accident risk, whereas the SSRIs are not associated with such effects. Clinically relevant differences in the behavioural toxicity of the SSRIs are highlighted.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 20 条
[1]  
AMADOBOCCARA I, 1994, ENCEPHALE, V20, P65
[2]   PROGNOSIS OF DEPRESSION IN THE ELDERLY - A COMPARISON WITH YOUNGER PATIENTS [J].
BRODATY, H ;
HARRIS, L ;
PETERS, K ;
WILHELM, K ;
HICKIE, I ;
BOYCE, P ;
MITCHELL, P ;
PARKER, G ;
EYERS, K .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 :589-596
[3]  
CURRIE DJ, 1994, IN PRESS HUMAN PSYCH
[4]  
FREEMANTLE N, 1994, BRIT MED J, V30, P249
[5]   A COMMUNITY STUDY OF DEPRESSION IN ADOLESCENT GIRLS .2. THE CLINICAL-FEATURES OF IDENTIFIED DISORDER [J].
GOODYER, I ;
COOPER, PJ .
BRITISH JOURNAL OF PSYCHIATRY, 1993, 163 :374-380
[6]  
GOODYER IM, 1993, BRIT J PSYCHIAT, V163, P369
[7]   PSYCHOPHARMACOLOGICAL EFFECTS OF SERTRALINE IN NORMAL, HEALTHY-VOLUNTEERS [J].
HINDMARCH, I ;
BHATTI, JZ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (02) :221-223
[9]  
Hindmarch I, 1987, HUMAN PSYCHOPHARMACO, V2, P177
[10]  
HINDMARCH I, 1994, IN PRESS MED SCI RES